Improved analogs and novel delivery systems for somatostatin octapeptides

Metabolism: Clinical and Experimental

Volumn 45, Issue SUPPL.1, 1996, Pages 24-26

  Moreau, J P ^a   Kim, S ^b   Dong, J Z ^b   Ignatious, F ^b   Jackson, S ^b   Moreau, S C ^b   Morgan, B A ^b   Touraud, F ^b   Taylor, J E ^b   Tissier, B ^b   Pellet, M ^b   Murphy, W ^b   Davis, T ^b  

^a Biomeasure Inc   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

BIM 23023; BIM 23060; BIM 23190; BIM 23197; BIM 23198; GROWTH HORMONE; GROWTH HORMONE RELEASING FACTOR; OCTREOTIDE; SOMATOSTATIN DERIVATIVE; SOMATOSTATIN RECEPTOR; UNCLASSIFIED DRUG;

ACROMEGALY; ADENOHYPOPHYSIS; ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; DRUG BIOAVAILABILITY; DRUG DESIGN; DRUG DISTRIBUTION; DRUG EXCRETION; DRUG FORMULATION; DRUG METABOLISM; DRUG POTENCY; DRUG RECEPTOR BINDING; DRUG SELECTIVITY; FEMALE; GROWTH HORMONE RELEASE; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; RECEPTOR AFFINITY;

AMINO ACID SEQUENCE; ANIMALS; CAPSULES; DELAYED-ACTION PREPARATIONS; DESIGNER DRUGS; DRUG DELIVERY SYSTEMS; FEMALE; HUMANS; MALE; MOLECULAR SEQUENCE DATA; RATS; RATS, SPRAGUE-DAWLEY; SOMATOSTATIN;

EID: 0038573796     PISSN: 00260495     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0026-0495(96)90074-8     Document Type: Article

References (7)

1. Lancranjan I, Bruns C, Grass P, et al: Sandostatin LAR: Pharmacokinetics, pharmacodynamics, efficacy and tolerability in acromegalic patients. Metabolism 44:18-26, 1995
2. Johnson MR, Chowdrey HS, Thomas F, et al: Pharmacokinetics and efficacy of the long-acting somatostatin analogue somatuline in acromegaly. Eur J Endocrinol 130:229-234, 1995
3. Ionic Molecular Conjugates of Biodegradable Polyesters and Bioactive Polypeptides. PCT Application WO 94/00148
4. Lemaire M, Azria M, Dannecker R, et al: Disposition of Sandostatin, a new synthetic somatostatin analogue, in rats. Drug Metab Dispos 17:699-703, 1989
5. Albert R, Marbach P, Bauer W, et al: SDZ CO 611: A highly potent glycated analog of somatostatin with improved oral activity. Life Sci 53:517-525, 1993
6. Kim SH, Dong JZ, Gordon TD, et al: Potent somatostatin analogs containing N-terminal modification. Proceedings of the 14th American Peptide Symposium, Columbus, OH, June 18-23, 1995 (abstr P223)
7. Raynor K, Murphy WA, Coy DH, et al: Cloned somatostatin receptors: Identification of subtype-selective peptides and demonstration of high affinity binding of linear peptides. Mol Pharmacol 43:838-844, 1993